Utah Medical Products (NASDAQ:UTMD) Stock Rating Lowered by BidaskClub

BidaskClub lowered shares of Utah Medical Products (NASDAQ:UTMD) from a hold rating to a sell rating in a research report report published on Monday morning, BidAskClub reports.

Shares of UTMD opened at $85.80 on Monday. Utah Medical Products has a one year low of $73.98 and a one year high of $110.25. The stock has a 50-day moving average price of $83.81. The firm has a market capitalization of $324.57 million, a PE ratio of 22.34 and a beta of 0.83.

Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, April 25th. The medical instruments supplier reported $0.84 EPS for the quarter. Utah Medical Products had a net margin of 42.07% and a return on equity of 16.47%. The company had revenue of $10.73 million during the quarter.

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 3rd. Shareholders of record on Friday, June 14th were issued a $0.275 dividend. This represents a $1.10 annualized dividend and a dividend yield of 1.28%. The ex-dividend date was Thursday, June 13th.

Institutional investors and hedge funds have recently made changes to their positions in the business. Prudential Financial Inc. boosted its holdings in shares of Utah Medical Products by 29.5% in the fourth quarter. Prudential Financial Inc. now owns 6,186 shares of the medical instruments supplier’s stock worth $514,000 after buying an additional 1,410 shares during the period. Martingale Asset Management L P boosted its holdings in shares of Utah Medical Products by 9.8% in the fourth quarter. Martingale Asset Management L P now owns 19,002 shares of the medical instruments supplier’s stock worth $1,579,000 after buying an additional 1,700 shares during the period. New York State Common Retirement Fund boosted its holdings in shares of Utah Medical Products by 12.9% in the fourth quarter. New York State Common Retirement Fund now owns 4,517 shares of the medical instruments supplier’s stock worth $375,000 after buying an additional 517 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Utah Medical Products by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 49,707 shares of the medical instruments supplier’s stock worth $4,128,000 after buying an additional 1,422 shares during the period. Finally, Mercer Global Advisors Inc. ADV acquired a new position in shares of Utah Medical Products in the first quarter worth about $224,000. Institutional investors own 73.63% of the company’s stock.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Featured Article: What is a Tariff?

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.